Lipid analysis of the major salivary glands in streptozotocin-diabetic rats and the effects of insulin treatment.
Two separate sets of experiments were performed on female Wistar rats made diabetic with streptozotocin: (1) a time-course study where groups of three animals were removed at weekly intervals, up to 4 weeks after induction of diabetes, with an age-matched group of control (normal) animals kept for 4 weeks; (2) six further animals were made diabetic and kept for 7 weeks; three of these were given insulin in the final week. At the required time the animals were anaesthetized and the salivary glands removed and preserved by fixation or freezing. The frozen tissues were later homogenized and the protein and lipid content analysed. Histologically, intracellular lipid droplets had accumulated in the majority of the diabetic salivary glands. In the time-course experiment, the visible amount of intracellular lipid reached a maximum after 2 weeks and then decreased, with a concomitant disappearance of interstitial lipid. The increased lipid content was not attributable to any one class. The fatty acid profiles of the glands showed an increase in the percentages of C18:0 (stearic acid) and C18:2w6 (linoleic acid) and a decrease in the percentages of C18:1w9 (oleic acid) and C20:4w6 (arachidonic acid). After 1 week of insulin treatment the lipid content and the fatty acid profiles returned to normal. Thus the effect of insulin on salivary gland lipid metabolism is rapid both in its occurrence and reversibility. The effects seen in the diabetic rats are considered to be due to a lack of insulin and not to the presence of streptozotocin.
Morris
P A
PA
Department of Molecular Biology and Biotechnology, Sheffield University, Western Bank, U.K.
Prout
R E
RE
Proctor
G B
GB
Garrett
J R
JR
Anderson
L C
LC
D000818:Animals; D001095:Arachidonic Acids / Q000032:analysis; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D005227:Fatty Acids / Q000032:analysis*; D005260:Female; D007328:Insulin / Q000627:therapeutic use*; D008041:Linoleic Acids / Q000032:analysis; D008055:Lipids / Q000032:analysis*; D009829:Oleic Acids / Q000032:analysis; D010306:Parotid Gland / Q000737:chemistry / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D012469:Salivary Glands / Q000737:chemistry* / Q000473:pathology; D012471:Salivary Proteins and Peptides / Q000032:analysis; D013229:Stearic Acids / Q000032:analysis; D013311:Streptozocin; D013361:Sublingual Gland / Q000737:chemistry / Q000473:pathology; D013363:Submandibular Gland / Q000737:chemistry / Q000473:pathology
D001095:Arachidonic Acids; D005227:Fatty Acids; D007328:Insulin; D008041:Linoleic Acids; D008055:Lipids; D009829:Oleic Acids; D012471:Salivary Proteins and Peptides; D013229:Stearic Acids; D013311:Streptozocin